Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Ho

Showing results (151-160 of 241) with videos related to

Pageof 25
Sort By:
Cell|December 29, 2022
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariantsQian Wang, Sho Iketani, Zhiteng Li, et al.
Plos Pathogens|March 6, 2018
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infectionsKshitij Wagh, Michael S Seaman, Marshall Zingg, et al.
Journal of Virology|November 27, 2004
Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in chinaLinqi Zhang, Zhiwei Chen, Yunzhen Cao, et al.
Science Translational Medicine|January 16, 2015
A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challengeChasity D Andrews, Yun Lan Yueh, William R Spreen, et al.
Lancet (London, England)|March 23, 2005
Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case reportMartin Markowitz, Hiroshi Mohri, Saurabh Mehandru, et al.
Cell|March 3, 2023
A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spikeBernadeta Dadonaite, Katharine H D Crawford, Caelan E Radford, et al.
Journal of Virology|February 12, 2002
Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapyXia Jin, Murugappan Ramanathan, Shady Barsoum, et al.
Frontiers in Immunology|September 19, 2022
Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigensMatheus Oliveira de Souza, Bharat Madan, I-Ting Teng, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic overall infectionsJose Victor Zambrana, Ian A Mellis, Abigail Shotwell, et al.
Nature Communications|November 21, 2025
Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic and overall infectionsJosé Victor Zambrana, Ian A Mellis, Abigail Shotwell, et al.
Pageof 25

Showing results (151-160 of 241) with videos related to

Sort By:
Pageof 25
Cell|December 29, 2022
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariantsQian Wang, Sho Iketani, Zhiteng Li, et al.
Plos Pathogens|March 6, 2018
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infectionsKshitij Wagh, Michael S Seaman, Marshall Zingg, et al.
Journal of Virology|November 27, 2004
Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in chinaLinqi Zhang, Zhiwei Chen, Yunzhen Cao, et al.
Science Translational Medicine|January 16, 2015
A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challengeChasity D Andrews, Yun Lan Yueh, William R Spreen, et al.
Lancet (London, England)|March 23, 2005
Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case reportMartin Markowitz, Hiroshi Mohri, Saurabh Mehandru, et al.
Cell|March 3, 2023
A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spikeBernadeta Dadonaite, Katharine H D Crawford, Caelan E Radford, et al.
Journal of Virology|February 12, 2002
Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapyXia Jin, Murugappan Ramanathan, Shady Barsoum, et al.
Frontiers in Immunology|September 19, 2022
Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigensMatheus Oliveira de Souza, Bharat Madan, I-Ting Teng, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic overall infectionsJose Victor Zambrana, Ian A Mellis, Abigail Shotwell, et al.
Nature Communications|November 21, 2025
Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic and overall infectionsJosé Victor Zambrana, Ian A Mellis, Abigail Shotwell, et al.
Pageof 25